Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features
H H Berendsen, L de Leij, S Poppema, et al.
Journal of Clinical Pathology
|
March 1, 1988
Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen
H H Berendsen, L de Leij, P E Postmus, et al.
British Journal of Cancer
|
December 1, 1992
Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma
R A Janssen, D T Sleijfer, A A Heijn, et al.
Biophysical Journal
|
August 1, 1993
Selective electrofusion of conjugated cells in flow
T C Bakker Schut, Y M Kraan, W Barlag, et al.
International Journal of Cancer
|
July 15, 1990
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance
G A Hospers, C Meijer, L de Leij, et al.
Journal of Hematotherapy
|
October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects
B J Kroesen, R A Janssen, J Buter, et al.
Molecular Microbiology
|
November 1, 1994
Mode of action of LciA, the lactococcin A immunity protein
K Venema, R E Haverkort, T Abee, et al.
British Journal of Cancer
|
May 1, 1993
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response
A Martens, R A Janssen, D T Sleijfer, et al.
International Journal of Cancer
|
June 9, 1995
Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model
B J Kroesen, W Helfrich, A Bakker, et al.
Cancer Research
|
August 1, 1989
Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up
E G de Vries, C Meijer, H Timmer-Bosscha, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features
H H Berendsen, L de Leij, S Poppema, et al.
Journal of Clinical Pathology
|
March 1, 1988
Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen
H H Berendsen, L de Leij, P E Postmus, et al.
British Journal of Cancer
|
December 1, 1992
Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma
R A Janssen, D T Sleijfer, A A Heijn, et al.
Biophysical Journal
|
August 1, 1993
Selective electrofusion of conjugated cells in flow
T C Bakker Schut, Y M Kraan, W Barlag, et al.
International Journal of Cancer
|
July 15, 1990
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance
G A Hospers, C Meijer, L de Leij, et al.
Journal of Hematotherapy
|
October 1, 1995
Bispecific monoclonal antibodies for intravenous treatment of carcinoma patients: immunobiologic aspects
B J Kroesen, R A Janssen, J Buter, et al.
Molecular Microbiology
|
November 1, 1994
Mode of action of LciA, the lactococcin A immunity protein
K Venema, R E Haverkort, T Abee, et al.
British Journal of Cancer
|
May 1, 1993
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response
A Martens, R A Janssen, D T Sleijfer, et al.
International Journal of Cancer
|
June 9, 1995
Reduction of EGP-2-positive pulmonary metastases by bispecific-antibody-redirected T cells in an immunocompetent rat model
B J Kroesen, W Helfrich, A Bakker, et al.
Cancer Research
|
August 1, 1989
Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up
E G de Vries, C Meijer, H Timmer-Bosscha, et al.
Page
of 9